As of January 23, 2025, Hoth Therapeutics (HOTH) has a market cap of $9.389 million USD. According to our data, Hoth Therapeutics is ranked No.8890 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 23, 2025 | $9.39 M |
81.82%
|
Dec 31, 2024 | $5.16 M |
-48.06%
|
Dec 29, 2023 | $9.94 M |
-81.54%
|
Dec 30, 2022 | $53.85 M |
-52.73%
|
Dec 31, 2021 | $0.11 B |
-72.15%
|
Dec 31, 2020 | $0.41 B |
-61.71%
|
Dec 31, 2019 | $1.07 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
DermTech
DMTK
|
$3.29 M |
3.287 M
|
USA
|
Cassava Sciences
SAVA
|
$0.12 B |
0.000 M
|
USA
|
Anavex Life Sciences
AVXL
|
$0.85 B |
0.000 M
|
USA
|
Vaxart
VXRT
|
$0.19 B |
-0.000 M
|
USA
|
Abeona Therapeutics
ABEO
|
$0.22 B |
0.000 M
|
USA
|
BioXcel Therapeutics
BTAI
|
$18.04 M |
0.000 M
|
USA
|
Cytokinetics
CYTK
|
$5.53 B |
-0.000 M
|
USA
|
Kezar Life Sciences
KZR
|
$46.70 M |
0.000 M
|
USA
|
Ovid Therapeutics
OVID
|
$49.92 M |
0.000 M
|
USA
|
Market Cap | = | HOTH Stock Price | * | HOTH Shares Outstanding |
= | $1.36 | * | 6.90 M | |
= | $9.39 M |